Glioblastoma Study
Bi-Weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
This clinical research study is currently seeking volunteers. It is designed to evaluate the safety and effectiveness of the investigational combination of medications in recurrent glioblastoma multiforme/gliosarcoma.
You may be eligible for this study if you:
- Are between 18 and 83 years of age
- Have a confirmed diagnosis of a glioblastoma multiforme/gliosarcoma
- Have completed at least two cycles of post-surgery chemotherapy
You would not be eligible for this study if you:
- Were previously treated with the study drug
- Have recently had a stroke or heart attack
Study Enrollment
If you are interested in learning more about this study, please complete the information below and our clinical research team will follow up with you. Please do not disclose confidential Protect Health Information as our system is not equipped with the necessary security.
